Table 3.
Resistance pattern and genetic profile of quinolone resistant Pseudomonas spp. isolates
| Isolate No. | Quinolone resistance profile | No. of quinolones with resistance | PMQR profile | No. of detected PMQR genes |
|---|---|---|---|---|
| Ps1 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps3 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps4 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps5 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps6 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps7 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps8 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps9 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD | 2 |
| Ps10 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps11 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps12 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrS | 2 |
| Pp13 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps14 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps15 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps16 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps17 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps18 | NAL, CIP, NOR, OFL, LEV, MOX | 6 | - | 0 |
| Ps19 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrS | 2 |
| Ps20 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrS | 2 |
| Ps21 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps23 | NAL, CIP, NOR, OFL, LEV, MOX | 6 | acc(6ʹ)-Ib-cr | 1 |
| Ps24 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 6 | qnrD | 1 |
| Ps25 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps26 | NAL, CIP, NOR, OFL, LEV, MOX | 7 | qnrD, qnrS | 2 |
| Ps27 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps28 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps29 | NAL, CIP, NOR, OFL, LEV, MOX | 6 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps30 | NAL, CIP, NOR, OFL, LEV, MOX | 6 | qnrD, qnrS | 2 |
| Ps31 | NAL | 1 | qnrS | 1 |
| Ps32 | NAL | 1 | qnrD | 1 |
| Ps33 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps34 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD | 2 |
| Ps35 | NAL, CIP, NOR, OFL, GEM, LEV, MOX | 7 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Pp36 | NAL, MOX | 2 | qnrD, qnrS | 2 |
| Ps37 | NAL, MOX | 2 | qnrD, qnrS | 2 |
| Ps38 | NAL, CIP, NOR, OFL, LEV, MOX | 6 | acc(6ʹ)-Ib-cr, qnrD, qnrS | 3 |
| Ps39 | NAL, NOR, OFL, LEV, MOX | 5 | qnrS | 1 |
| Ps40 | NAL, CIP, NOR, OFL, MOX | 5 | qnrD | 1 |
| Ps41 | NOR | 1 | - | 0 |
Abbreviations: NT, not tested; NAL; Nalidixic acid, CIP; Ciprofloxacin, NOR; Norfloxacin, OFL; Ofloxacin, GEM; Gemifloxacin, LEV; Levofloxacin, MOX; Moxifloxacin; PMQR, plasmid-mediated quinolone resistance.